Parathyroid hormone measurements, guidelines statements and clinical treatments: a real-world cautionary tale

被引：5

作者：

Garrett, Giorgia ^{[1
]}

Goldsmith, David J. A. ^{[2
]}

机构：

[1] E Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England

[2] Guys Hosp, Kings Hlth Partners AHSC, London SE1 9RT, England

来源：

ANNALS OF CLINICAL BIOCHEMISTRY | 2012年 / 49卷

关键词：

D O I：

10.1258/acb.2011.011254

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

100118 [医学信息学]; 100208 [临床检验诊断学];

摘要：

引用

页码：4 / 6

页数：3

共 13 条

[1]

Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease [J].

Almond, Alison ;

Ellis, Andrew R. ;

Walker, Simon W. .

ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :63-67

[2]

Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values [J].

Cavalier, Etienne ;

Delanaye, Pierre ;

Vranken, Laura ;

Bekaert, Anne-Catherine ;

Carlisi, Agnes ;

Chapelle, Jean-Paul ;

Souberbielle, Jean-Claude .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) :1950-1956

[3]

On the evolving nature of understanding dialysis-related disorders [J].

Eknoyan, G ;

Lindberg, JS .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3

[4]

Variability of Parathyroid Hormone and Other Markers of Bone Mineral Metabolism in Patients Receiving Hemodialysis [J].

Gardham, Clare ;

Stevens, Paul E. ;

Delaney, Michael P. ;

LeRoux, Marica ;

Coleman, Adrian ;

Lamb, Edmund J. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (07) :1261-1267

[5]

Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae [J].

Gifford, F. J. ;

Methven, S. ;

Boag, D. E. ;

Spalding, E. M. ;

MacGregor, M. S. .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2011, 104 (12) :1045-1053

[6]

Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study [J].

Iimori, Soichiro ;

Mori, Yoshihiro ;

Akita, Wataru ;

Kuyama, Tamaki ;

Takada, Shigeru ;

Asai, Tomoki ;

Kuwahara, Michio ;

Sasaki, Sei ;

Tsukamoto, Yusuke .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) :345-351

[7]

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study [J].

Ketteler, Markus ;

Martin, Kevin J. ;

Cozzolino, Mario ;

Goldsmith, David ;

Sharma, Amit ;

Khan, Samina ;

Dumas, Emily ;

Amdahl, Michael ;

Marx, Steven ;

Audhya, Paul .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) :1942-1949

[8]

Foreword [J].

Eckardt, Kai-Uwe ;

Kasiske, Bertram L. .

KIDNEY INTERNATIONAL, 2009, 76 :S1-S2

[9]

Parathyroid hormone, kidney disease, evidence and guidelines [J].

Lamb, Edmund J. ;

Vickery, Susan ;

Ellis, Andy R. .

ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 :1-4

[10]

Leveraging guidelines: understanding heart failure, organizing care. Commentary on the 2010 NICE chronic heart failure guideline update [J].

McIntyre, Hugh Farrell .

EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (01) :14-17

← 1 2 →